Abstract
(1) Objective: Blood glucose forecasting in type 1 diabetes (T1D) management is a maturing field with numerous algorithms being published and a few of them having reached the commercialisation stage. However, accurate long-term glucose predictions (e.g., >60 min), which are usually needed in applications such as precision insulin dosing (e.g., an artificial pancreas), still remain a challenge. In this paper, we present a novel glucose forecasting algorithm that is well-suited for long-term prediction horizons. The proposed algorithm is currently being used as the core component of a modular safety system for an insulin dose recommender developed within the EU-funded PEPPER (Patient Empowerment through Predictive PERsonalised decision support) project. (2) Methods: The proposed blood glucose forecasting algorithm is based on a compartmental composite model of glucose–insulin dynamics, which uses a deconvolution technique applied to the continuous glucose monitoring (CGM) signal for state estimation. In addition to commonly employed inputs by glucose forecasting methods (i.e., CGM data, insulin, carbohydrates), the proposed algorithm allows the optional input of meal absorption information to enhance prediction accuracy. Clinical data corresponding to 10 adult subjects with T1D were used for evaluation purposes. In addition, in silico data obtained with a modified version of the UVa-Padova simulator was used to further evaluate the impact of accounting for meal absorption information on prediction accuracy. Finally, a comparison with two well-established glucose forecasting algorithms, the autoregressive exogenous (ARX) model and the latent variable-based statistical (LVX) model, was carried out. (3) Results: For prediction horizons beyond 60 min, the performance of the proposed physiological model-based (PM) algorithm is superior to that of the LVX and ARX algorithms. When comparing the performance of PM against the secondly ranked method (ARX) on a 120 min prediction horizon, the percentage improvement on prediction accuracy measured with the root mean square error, A-region of error grid analysis (EGA), and hypoglycaemia prediction calculated by the Matthews correlation coefficient, was , , and , respectively. Although showing a trend towards improvement, the addition of meal absorption information did not provide clinically significant improvements. (4) Conclusion: The proposed glucose forecasting algorithm is potentially well-suited for T1D management applications which require long-term glucose predictions.
Highlights
Type 1 diabetes (T1D) is an autoimmune condition characterized by elevated blood glucose levels due to the lack of endogenous insulin production [1]
The proposed glucose prediction algorithm is based on the composite minimal model of glucose–insulin regulation in T1D [30] that uses deconvolution of the continuous glucose monitoring (CGM) signal to estimate some of the model states
In order to show the consistency of the results at the individual level, the root mean square error (RMSE) results for each of the evaluated subjects are presented in Appendix B (Table A4)
Summary
Type 1 diabetes (T1D) is an autoimmune condition characterized by elevated blood glucose levels due to the lack of endogenous insulin production [1]. Current therapies for T1D management require measuring capillary glucose levels several times per day and the administration of insulin by means of multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) with pumps. The improvement on accuracy of subcutaneous continuous glucose monitoring (CGM) has enabled access to virtually continuous glucose concentrations measurements (e.g., every 5 min), glucose trends, and their retrospective analysis. CGM technology has opened the door to new technologies for managing glucose levels such as sensor-augmented insulin pumps with low-glucose insulin suspension [4] and the artificial pancreas [5]. One additional benefit of the CGM technology is that it facilitates the forecasting of blood glucose levels, and enables pre-emptive action to avoid undesired events, such as hypoglycaemia and hyperglycaemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.